BS EN ISO 14708-2:2022
$215.11
Implants for surgery. Active implantable medical devices – Cardiac pacemakers
Published By | Publication Date | Number of Pages |
BSI | 2022 | 80 |
This document specifies requirements that are applicable to those active implantable medical devices intended to treat bradyarrhythmias and devices that provide therapies for cardiac resynchronization. The tests that are specified in this document are type tests, and are to be carried out on samples of a device to show compliance. This document was designed for bradyarrhythmia pulse generators used with endocardial leads or epicardial leads. At the time of this edition, the authors recognized the emergence of leadless technologies for which adaptations of this part will be required. Such adaptations are left to the discretion of manufacturers incorporating these technologies. This document is also applicable to some non-implantable parts and accessories of the devices (see Note 1). The electrical characteristics of the implantable pulse generator or lead are determined either by the appropriate method detailed in this particular standard or by any other method demonstrated to have an accuracy equal to, or better than, the method specified. In case of dispute, the method detailed in this particular standard applies. Any features of an active implantable medical device intended to treat tachyarrhythmias are covered by ISO 14708-6. NOTE 1 The device that is commonly referred to as an active implantable medical device can in fact be a single device, a combination of devices, or a combination of a device or devices and one or more accessories. Not all of these parts are required to be either partially or totally implantable, but there is a need to specify some requirements of non-implantable parts and accessories if they could affect the safety or performance of the implantable device. NOTE 2 In this document, terms printed in italics are used as defined in Clause 3. Where a defined term is used as a qualifier in another term, it is not printed in italics unless the concept thus qualified is also defined.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
4 | European foreword Endorsement notice |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 2 Normative references |
10 | 3 Terms and definitions |
13 | 4 Symbols and abbreviated terms |
14 | 5 General requirements for non-implantable parts 5.1 General requirements for non-implantable parts 5.2 General requirements for software 5.3 Usability of non-implantable parts 5.4 Data security and protection from harm caused by unauthorized information tampering 5.5 General requirements for risk management 5.6 Misconnection of parts of the active implantable medical device 6 Measurements of implantable pulse generator and lead characteristics 6.1 Measurement of implantable pulse generator characteristics 6.1.1 General considerations 6.1.2 Measurement of pulse amplitude, pulse duration, pulse interval, and pulse rate |
15 | 6.1.3 Measurement of sensitivity (epos and eneg) |
16 | 6.1.4 Measurement of input impedance (Zin) 6.1.5 Measurement of escape interval (te) |
18 | 6.1.6 Measurement of sensing refractory period (tsr) |
21 | 6.1.7 Measurement of pacing refractory period (tpr) (applicable only to inhibited implantable pulse generators) 6.1.8 Measurement of AV interval (applicable only to dual-chamber implantable pulse generators) |
22 | 6.1.9 Measurement of the post-ventricular atrial refractory period (PVARP) (applicable only to implantable pulse generators with atrial sensing and ventricular pacing) |
23 | 6.1.10 Measurement of the atrial-ventricular (AV) interval after sensing (applicable only to implantable pulse generators with atrial sensing and ventricular pacing) |
24 | 6.2 Measurement of the lead pacing impedance (Zp) 6.2.1 Measurement equipment accuracy 6.2.2 Methods of measuring lead pacing impedance |
25 | 6.2.3 In vitro method for measurement of lead pacing impedance |
26 | 7 General arrangement of the packaging 8 General markings for active implantable medical devices 9 Markings on the sales packaging |
28 | 10 Construction of the sales packaging 11 Markings on the sterile pack |
30 | 12 Construction of the non-reusable pack 13 Markings on the active implantable medical device |
31 | 14 Protection from unintentional biological effects being caused by the active implantable medical device 15 Protection from harm to the patient or user caused by external physical features of the active implantable medical device 16 Protection from harm to the patient caused by electricity |
33 | 17 Protection from harm to the patient caused by heat 18 Protection from ionizing radiation released or emitted from the active implantable medical device |
34 | 19 Protection from unintended effects caused by the device |
35 | 20 Protection of the device from damage caused by external defibrillators 21 Protection of the device from changes caused by high power electrical fields applied directly to the patient 22 Protection of the active implantable medical device from changes caused by miscellaneous medical treatments 23 Protection of the active implantable medical device from mechanical forces |
39 | 24 Protection of the active implantable medical device from damage caused by electrostatic discharge 25 Protection of the active implantable medical device from damage caused by atmospheric pressure changes |
40 | 26 Protection of the active implantable medical device from damage caused by temperature changes 27 Protection of the active implantable medical device from electromagnetic non-ionizing radiation 28 Accompanying documentation |
45 | Annex A (informative) Relationship between the fundamental principles in ISO/TR 14283 and the clauses of this document |
65 | Annex B (informative) Rationale |
73 | Annex C (informative) Code for describing modes of implantable pulse generators |
76 | Annex D (normative) Pulse forms |
78 | Bibliography |